輸液療法機器の世界市場 - 市場考察、競合情勢、市場予測（2030年）

世界の輸液療法機器の市場規模は、2030年までに776億5,000万米ドルに達すると予測され、2024年～2030年の予測期間にCAGRで6.56%の成長が見込まれます。輸液療法機器に対する需要の急増は主に、糖尿病やがんなどの慢性疾患の有病率の上昇によって促進されています。輸液療法機器は幅広い臨床治療を網羅し、製品の上市の顕著な増加もあり、市場は大幅な伸びを示しています。これらの要因が総体的に、2024年～2030年の予測期間を通じて、輸液療法機器市場の成長軌道の向上に寄与します。

輸液療法機器の市場力学

世界中での糖尿病とがんの流行が、輸液療法機器市場の大幅な成長を促進しています。国際糖尿病連合（IDF）によると、2021年に20～79歳の成人5億3,700万人が糖尿病を患っていると推定されています。この数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。さらに、5億4,100万人が耐糖能異常（IGT）であり、2型糖尿病を発症するリスクが高いと報告されています。特筆すべきは、成人糖尿病患者の4分の3が低中所得国に居住しており、インスリンポンプのような先進の医療機器へのニーズが極めて高いことです。これらの医療機器は、インスリンの持続的かつ正確な投与に不可欠であり、効果的な血糖管理に不可欠です。

輸液療法機器の需要は、米国がん協会が発表したがん統計によっても後押しされています。2020年に、非黒色腫皮膚がんの1,810万例を除き、世界中で1,930万例の新たながん患者が発生すると推定されています。乳がんは新規症例の11.7％を占め、肺がんの11.4％を上回り、もっとも多く診断されるがんとなっています。その他のがんでは、大腸がん（10.0％）、前立腺がん（7.3％）、胃がん（5.6％）が多いです。輸液療法は化学療法の実施に不可欠であり、がん治療におけるこれらの機器の重要な役割がさらに強く示されています。

輸液療法機器市場はまた、業界企業間の提携やパートナーシップの増加からも恩恵を受けています。例えば、2023年8月、フィンランドの医療技術企業であるMonidor Oyは、国際的な主要医療機器メーカーであるB. Braunと提携し、遠隔輸液療法モニタリングを強化しました。このようなパートナーシップは、輸液療法の分野の進歩において極めて重要です。

もう1つの重大な発展として、Eitan Medicalは2021年4月、画期的なコネクテッドマルチセラピー外来輸液システム「Avoset」を発表しました。Avosetは、そのコンパクトな設計と遠隔モニタリング機能により、急性期後のケアと特殊輸液療法を変革し、患者の安全性とユーザーエクスペリエンスを向上させるよう設計されています。

こうした前向きな動向にもかかわらず、市場は輸液療法機器の高いコストや使用に伴う感染リスクなどの課題に直面しています。これらの要因は、2024年～2030年の予測期間に市場の成長を抑制する可能性があります。しかし、糖尿病やがんなどの慢性疾患を効果的に管理するニーズの高まりに後押しされ、輸液療法機器市場の全体的な拡大は続くと予測されます。

輸液療法機器市場のセグメント分析

シリンジ輸液ポンプセグメントが、2023年に輸液療法機器市場で大きな収益シェアを獲得する見通しです。精度の高さで知られるシリンジ輸液ポンプ（シリンジドライバー）は、薬や栄養剤などの少量の輸液を患者の血流に直接投与するのに極めて重要です。

シリンジ輸液ポンプには複数の利点があり、臨床現場で欠かせないものとなっています。これらの機器は汎用性が高く、携帯使用と固定使用の両方に向けて設計されており、温度制御に用いる内部ヒーターが組み込まれています。この機能は、有効性を維持するために特定の温度設定が必要な輸液の投与に特に有益です。さらに、シリンジポンプはコンピューターとの相互作用が可能であり、医療提供者は機器をプログラムして精度を高めたり、輸液の履歴を追跡したりすることができ、エラーの可能性を最小化することができます。

当レポートでは、世界の輸液療法機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 輸液療法機器市場レポートのイントロダクション

第2章 輸液療法機器市場のエグゼクティブサマリー

• 市場の概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 輸液療法機器市場の主な要因の分析

• 輸液療法機器市場の促進要因
• 輸液療法機器市場の抑制要因と課題
• 輸液療法機器市場の機会

第6章 輸液療法機器市場のポーターのファイブフォース分析

第7章 輸液療法機器市場の評価

• 製品タイプ別
  • シリンジ輸液ポンプ
  • 大容量ポンプ（LVP）
  • エラストマーポンプ
  • その他
• 可動性別
  • 携帯式輸液ポンプ
  • 固定式輸液ポンプ
• 用途別
  • 多発性硬化症
  • 糖尿病
  • 関節リウマチ
  • がん
• エンドユーザー
  • 病院、診療所
  • 外来手術センター
  • 在宅ケア
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 輸液療法機器市場の企業と製品のプロファイル

• Fresenius Kabi AG
• Ossila
• Ace-medical
• ICU Medical
• Chmyx inc.
• Mindray
• Baxter
• Becton, Dickinson and Company
• Micrel Medical Devices SA
• AKAS Infusions
• Narang Medical Limited
• Monidor Oy.
• Smiths Group plc.
• B. Braun SE
• Trivitron Healthcare
• Eitan Medical

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Infusion Therapy Devices Market in Global (2021-2030)
• Table 3: Infusion Therapy Devices Market in Global by Product Type (2021-2030)
• Table 4: Infusion Therapy Devices Market in Global by Mobility (2021-2030)
• Table 5: Infusion Therapy Devices Market in Global by Application (2021-2030)
• Table 6: Infusion Therapy Devices Market in Global by End-User (2021-2030)
• Table 7: Infusion Therapy Devices Market in Global by Geography (2021-2030)
• Table 8: Infusion Therapy Devices Market in North America (2021-2030)
• Table 9: Infusion Therapy Devices Market in North America by Country (2021-2030)
• Table 10: Infusion Therapy Devices Market in the US (2021-2030)
• Table 11: Infusion Therapy Devices Market in Canada (2021-2030)
• Table 12: Infusion Therapy Devices Market in Mexico (2021-2030)
• Table 13: Infusion Therapy Devices Market in Europe (2021-2030)
• Table 14: Infusion Therapy Devices Market in Europe by Country (2021-2030)
• Table 15: Infusion Therapy Devices Market in France (2021-2030)
• Table 16: Infusion Therapy Devices Market in Germany (2021-2030)
• Table 17: Infusion Therapy Devices Market in the United Kingdom (2021-2030)
• Table 18: Infusion Therapy Devices Market in Italy (2021-2030)
• Table 19: Infusion Therapy Devices Market in Spain (2021-2030)
• Table 20: Infusion Therapy Devices Market in the Rest of Europe (2021-2030)
• Table 21: Infusion Therapy Devices Market in Asia-Pacific (2021-2030)
• Table 22: Infusion Therapy Devices Market in Asia-Pacific by Country (2021-2030)
• Table 23: Infusion Therapy Devices Market in China (2021-2030)
• Table 24: Infusion Therapy Devices Market in Japan (2021-2030)
• Table 25: Infusion Therapy Devices Market in India (2021-2030)
• Table 26: Infusion Therapy Devices Market in Australia (2021-2030)
• Table 27: Infusion Therapy Devices Market in South Korea (2021-2030)
• Table 28: Infusion Therapy Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 29: Infusion Therapy Devices Market in the Rest of the World (2021-2030)
• Table 30: Infusion Therapy Devices Market in the Middle East (2021-2030)
• Table 31: Infusion Therapy Devices Market in Africa (2021-2030)
• Table 32: Infusion Therapy Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Infusion Therapy Devices Market in Global (2021-2030)
• Figure 3: Infusion Therapy Devices Market in Global by Product Type (2021-2030)
• Figure 4: Infusion Therapy Devices Market in Global by Mobility (2021-2030)
• Figure 5: Infusion Therapy Devices Market in Global by Application (2021-2030)
• Figure 6: Infusion Therapy Devices Market in Global by End-User (2021-2030)
• Figure 7: Infusion Therapy Devices Market in Global by Geography (2021-2030)
• Figure 8: Infusion Therapy Devices Market in North America (2021-2030)
• Figure 9: Infusion Therapy Devices Market in North America by Country (2021-2030)
• Figure 10: Infusion Therapy Devices Market in the US (2021-2030)
• Figure 11: Infusion Therapy Devices Market in Canada (2021-2030)
• Figure 12: Infusion Therapy Devices Market in Mexico (2021-2030)
• Figure 13: Infusion Therapy Devices Market in Europe (2021-2030)
• Figure 14: Infusion Therapy Devices Market in Europe by Country (2021-2030)
• Figure 15: Infusion Therapy Devices Market in France (2021-2030)
• Figure 16: Infusion Therapy Devices Market in Germany (2021-2030)
• Figure 17: Infusion Therapy Devices Market in the United Kingdom (2021-2030)
• Figure 18: Infusion Therapy Devices Market in Italy (2021-2030)
• Figure 19: Infusion Therapy Devices Market in Spain (2021-2030)
• Figure 20: Infusion Therapy Devices Market in the Rest of Europe (2021-2030)
• Figure 21: Infusion Therapy Devices Market in Asia-Pacific (2021-2030)
• Figure 22: Infusion Therapy Devices Market in Asia-Pacific by Country (2021-2030)
• Figure 23: Infusion Therapy Devices Market in China (2021-2030)
• Figure 24: Infusion Therapy Devices Market in Japan (2021-2030)
• Figure 25: Infusion Therapy Devices Market in India (2021-2030)
• Figure 26: Infusion Therapy Devices Market in Australia (2021-2030)
• Figure 27: Infusion Therapy Devices Market in South Korea (2021-2030)
• Figure 28: Infusion Therapy Devices Market in Rest of Asia-Pacific (2021-2030)
• Figure 29: Infusion Therapy Devices Market in the Rest of the World (2021-2030)
• Figure 30: Infusion Therapy Devices Market in the Middle East (2021-2030)
• Figure 31: Infusion Therapy Devices Market in Africa (2021-2030)
• Figure 32: Infusion Therapy Devices Market in South America (2021-2030)
• Figure 33: Market Drivers
• Figure 34: Market Barriers
• Figure 35: Marker Opportunities
• Figure 36: PORTER'S Five Force Analysis

Infusion Therapy Devices Market By Product Type (Syringe Infusion Pumps, Large Volume Pumps, Elastomeric Pumps, And Others), Mobility (Portable Infusion Pumps, And Stationary Infusion Pumps), Application (Multiple Sclerosis, Diabetes, Rheumatoid Arthritis, Cancer, And Others), End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Homecare And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady cagr forecast till 2030 owing to rise in the prevalence of chronic disorders and increasing clinical applications of infusion therapy devices

The global Infusion Therapy Devices market is estimated to grow at a CAGR of 6.56% during the forecast period from 2024 to 2030 to reach USD 77.65 billion by 2030. The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing. These factors collectively contribute to fostering a positive trajectory for the growth of the infusion therapy devices market throughout the forecast period spanning from 2024 to 2030.

Infusion Therapy Devices Market Dynamics:

The global prevalence of diabetes and cancer is driving significant growth in the market for infusion therapy devices. According to the International Diabetes Federation (IDF), in 2021, an estimated 537 million adults aged 20-79 were living with diabetes. This number is projected to rise to 643 million by 2030 and 783 million by 2045. Additionally, 541 million individuals were reported to have Impaired Glucose Tolerance (IGT), putting them at high risk of developing Type 2 diabetes. Notably, three-quarters of adults with diabetes reside in low- and middle-income countries, where the need for advanced medical devices like insulin pumps is crucial. These devices are essential for continuous and precise insulin delivery, and vital for effective blood sugar management.

The demand for infusion therapy devices is also bolstered by the cancer statistics published by the American Cancer Society. In 2020, there were an estimated 19.3 million new cancer cases worldwide, excluding 18.1 million cases of non-melanoma skin cancer. Breast cancer has emerged as the most commonly diagnosed cancer, comprising 11.7% of new cases, surpassing lung cancer, which accounts for 11.4% of cases. The other prevalent cancers include colorectal (10.0%), prostate (7.3%), and stomach (5.6%). Infusion therapy is integral to chemotherapy delivery, further underscoring the critical role of these devices in cancer treatment.

The infusion therapy devices market is also benefiting from increased collaborations and partnerships among industry players. For instance, in August 2023, Monidor Oy, a Finnish health technology company, partnered with B. Braun, a leading international medical device manufacturer, to enhance remote IV therapy monitoring. Such partnerships are pivotal in advancing the field of infusion therapy.

In another significant development, Eitan Medical introduced a groundbreaking connected multi-therapy ambulatory infusion system, Avoset, in April 2021. Avoset is designed to transform post-acute care and specialized infusion therapy with its compact design and remote monitoring capabilities, enhancing patient safety and user experience.

Despite these positive trends, the market faces challenges such as the high cost of infusion therapy devices and the risk of infection associated with their use. These factors may restrain market growth during the forecast period of 2024 to 2030. However, the overall expansion of the infusion therapy device market is expected to continue, propelled by the rising need to manage chronic diseases like diabetes and cancer effectively.

Infusion Therapy Devices Market Segment Analysis:

Infusion Therapy Devices Market by Product Type (Syringe Pumps, Large Volume Pumps (LVP), Elastomeric Pumps, and Others), Mobility (Portable Infusion Pumps, and Stationary Pumps), Application (Multiple Sclerosis, Diabetes, Rheumatoid Arthritis, Cancer, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The syringe infusion pump segment is poised to capture a substantial revenue share of the infusion therapy devices market in 2023. Known for their precision, syringe infusion pumps, or syringe drivers, are crucial for administering small volumes of fluids, such as medications or nutrients, directly into a patient's bloodstream.

Syringe infusion pumps offer several advantages, making them indispensable in clinical settings. These devices are versatile, designed for both portable and stationary use, and incorporate an internal heater for temperature control. This feature is particularly beneficial for administering fluids that require specific temperature settings to maintain efficacy. Furthermore, syringe pumps can interface with computers, allowing healthcare providers to program the device for enhanced accuracy and to track the history of infusions, minimizing the potential for errors.

The capability to deliver fluids with higher viscosity is another notable benefit. These pumps can operate continuously for up to 24 hours, ensuring that patients receive a consistent and precise dosage of medication over a specified period. They also allow for the mixing and administering of multiple medications simultaneously, significantly reducing the need for frequent injections and improving patient comfort.

The demand for syringe infusion pumps is expected to grow due to their ability to deliver an accurate dosage over extended periods, which is increasingly essential in both acute and chronic care settings. This growth is further supported by the introduction of new and innovative products that have received regulatory approvals. For example, in August 2021, Baxter's Novum IQ syringe infusion pump received FDA 510(k) clearance. This device enhances the infusion process with advanced safety features, improved connectivity, configurable anesthesia care settings, and a user-friendly interface, emphasizing precision and reliability in medication delivery.

Given these developments, the syringe infusion pump segment is anticipated to experience notable growth, significantly contributing to the expansion of the overall infusion therapy device market from 2024 to 2030.

North America Is Expected To Dominate The Overall Infusion Therapy Devices Market:

North America is projected to dominate the Infusion Therapy Devices market in 2023, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis. The region's robust growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.

According to 2023 data from the Centers for Disease Control and Prevention (CDC), approximately 53.2 million people, or one in five U.S. adults, had doctor-diagnosed arthritis between 2019 and 2021. Arthritis is more prevalent among women (20.9%) than men (16.3%), and the likelihood of developing the condition increases with age. Notably, the prevalence of arthritis is higher among those with no leisure-time physical activity (30.9%) compared to those who are somewhat active (27.0%) or meet physical activity recommendations (18.8%). For individuals with arthritis where oral medications are ineffective, infusion therapy serves as a vital alternative, offering direct and rapid delivery of medication into the bloodstream.

The market is also stimulated by the strategic activities of leading companies based in the region, such as Mindray, Baxter, and Becton, Dickinson and Company. These firms play a critical role in the sector's growth through continuous innovation and new product offerings. For instance, in February 2023, Mindray launched its BeneFusion i and u Series infusion systems, which are notable for their high precision and user-friendly design. Featuring an intuitive full touch screen and a flat design that highlights essential parameters, the BeneFusion series enhances visibility and usability for medical staff, allowing for safer and more precise operations.

The convergence of these factors, along with ongoing product launches and regulatory approvals, underscores the significant role North America will continue to play in driving the growth of the global Infusion Therapy Devices market from 2024 to 2030.

Infusion Therapy Devices Market Key Players:

Some of the key market players operating in the Infusion Therapy Devices Market include Fresenius Kabi AG, Ossila, Ace-medical, ICU Medical, Chmyx Inc., Mindray, Baxter, Becton, Dickinson and Company, Micrel Medical Devices SA, AKAS Infusions, Narang Medical Limited, Monidor Oy., Smiths Group plc., B. Braun SE, Trivitron Healthcare, Eitan Medical, and Others.

Recent Developmental Activities In The Infusion Therapy Devices Market:

• In August 2021, Baxter got the approval of U.S. Food Drug Administration (FDA) 510 (k) clearance for its Novum IQ syringe infusion pump.
• In January 2022, ICU Medical Inc. finalized the acquisition of Smiths Medical from Smiths Group plc. This strategic move brings together a comprehensive portfolio encompassing syringe infusion devices, ambulatory infusion devices, vascular access solutions, and vital care products. By integrating the ambulatory infusion devices and vascular access offerings from Smiths Group plc with ICU Medical's Vital care products, the newly formed entity emerges as a prominent player in the infusion therapy sector, poised to exert a significant global presence.

Key Takeaways From The Infusion Therapy Devices Market Report Study

• Market size analysis for current Infusion Therapy Devices market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Infusion Therapy Devices market.
• Various opportunities are available for the other competitors in the Infusion Therapy Devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current Infusion Therapy Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Infusion Therapy Devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Infusion Therapy Device Market Report Study

• Infusion Therapy Devices product providers
• Research organizations and consulting companies
• Infusion Therapy Devices organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Infusion Therapy Devices
• Various end-users who want to know more about the infusion therapy device market and the latest innovations and developments in the infusion therapy device market.

Frequently Asked Questions For The Infusion Therapy Devices Market

1. What are Infusion Therapy Devices?

An infusion pump is a medical device utilized to administer fluids, including nutrients and medications, into a patient's body with precise control over the dosage. Widely employed across various clinical environments such as hospitals, nursing homes, and home care settings, these devices play a crucial role in medical treatment.

2. What is the market for global Infusion Therapy Devices?

The global Infusion Therapy Devices market is estimated to grow at a CAGR of 6.56% during the forecast period from 2024 to 2030 to reach USD 77.65 billion by 2030.

3. What are the drivers for the global infusion therapy devices market?

The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing. These factors collectively contribute to fostering a positive trajectory for the growth of the infusion therapy device market throughout the forecast period spanning from 2024 to 2030.

4. Who are the key players operating in the global infusion therapy devices market?

Some of the key market players operating in the Infusion Therapy Devices market include Fresenius Kabi AG, Ossila, Ace-medical, ICU Medical, Chmyx Inc., Mindray, Baxter, Becton, Dickinson and Company, Micrel Medical Devices SA, AKAS Infusions, Narang Medical Limited, Monidor Oy., Smiths Group plc., B. Braun SE, Trivitron Healthcare, Eitan Medical, and others.

5. Which region has the highest share in the infusion therapy devices market?

North America is projected to dominate the Infusion Therapy Devices market in 2023, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis. The region's robust growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.

Table of Contents

1. Infusion Therapy Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Infusion Therapy Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Infusion Therapy Devices Market Key Factors Analysis

• 5.1. Infusion Therapy Devices Market Drivers
  • 5.1.1. Growing prevalence of Diabetes and other Chronic diseases
  • 5.1.2. Growing geriatric population
• 5.2. Infusion Therapy Devices Market Restraints and Challenges
  • 5.2.1. High Cost of Infusion Therapy Devices
  • 5.2.2. Risk of developing infections while using infusion therapy device
• 5.3. Infusion Therapy Devices Market Opportunity
  • 5.3.1. Advancing smart technologies like- real-time monitoring, connectivity, and personalized treatment plans.

6. Infusion Therapy Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes s
• 6.5. Competitive Rivalry

7. Infusion Therapy Devices Market Assessment

• 7.1. By Product Type
  • 7.1.1. Syringe Infusion Pumps
  • 7.1.2. Large Volume Pumps (LVP)
  • 7.1.3. Elastomeric Pumps
  • 7.1.4. Others
• 7.2. By Mobility
  • 7.2.1. Portable Infusion Pumps
  • 7.2.2. Stationary Infusion Pumps
• 7.3. By Application
  • 7.3.1. Multiple Sclerosis
  • 7.3.2. Diabetes
  • 7.3.3. Rheumatoid Arthritis
  • 7.3.4. Cancer
  • 7.3.5. Others
• 7.4. End-User
  • 7.4.1. Hospitals and Clinics
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Homecare
  • 7.4.4. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. United States Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.1.2. Canada Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.1.3. Mexico Infusion Therapy Devices Market Size in USD million (2021-2030)
  • 7.5.2. Europe
    • 7.5.2.1. France Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.2.2. Germany Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.2.3. United Kingdom Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.2.4. Italy Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.2.5. Spain Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.2.6. Rest of Europe Infusion Therapy Devices Market Size in USD million (2021-2030)
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. China Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.3.2. Japan Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.3.3. India Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.3.4. Australia Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.3.5. South Korea Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.3.6. Rest of Asia-Pacific Infusion Therapy Devices Market Size in USD million (2021-2030)
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. Middle East Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.4.2. Africa Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.4.3. South America Infusion Therapy Devices Market Size in USD million (2021-2030)

8. Infusion Therapy Devices Market Company and Product Profiles

• 8.1. Fresenius Kabi AG
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Ossila
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Ace-medical
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. ICU Medical
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Chmyx inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Mindray
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Baxter
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Becton, Dickinson and Company
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Micrel Medical Devices SA
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. AKAS Infusions
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Narang Medical Limited
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Monidor Oy.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Smiths Group plc.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. B. Braun SE
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Trivitron Healthcare
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Eitan Medical
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us